The Changing Face of Breast Cancer: Why More Young Women in Africa Are Being Diagnosed, And What They Can Do About It

When many people think of breast cancer, they imagine it as a disease that mostly affects older women. Yet doctors in sub-Saharan Africa are raising a red flag; more and more younger women are being diagnosed, often much earlier than their counterparts in Western countries. This troubling trend is not limited to breast cancer alone; other cancers are also appearing more frequently in younger people. While genetics may play a role, more research is needed to fully understand whether environmental factors, lifestyle, or yet-unidentified risks are also driving this pattern.
This shift carries profound implications for how women of all ages should think about their health. The first and most important message is that every woman must know her breasts. Being familiar with how your breasts normally look and feel can help you quickly notice if something unusual develops, whether it’s a lump, skin dimpling, nipple discharge, or any other change. For younger women, this awareness is even more vital because routine mammograms are not typically recommended until after age 40. Instead, doctors often rely on ultrasounds, which are better suited for examining younger, denser breast tissue.
Breast density itself is another term that can be confusing. Simply put, it describes how the breast appears on imaging. Younger women usually have more dense breasts because they contain more milk-producing (glandular) tissue. On a scan, this makes the breast look more solid and compact. While density doesn’t necessarily increase the risk of cancer, it can make it harder for mammograms to detect problems, which is why alternative imaging like ultrasound or MRI may be recommended.
For many women, one of the hardest questions is how treatment might affect fertility. Chemotherapy and certain hormonal treatments can temporarily disrupt the cycle of egg release, and in some cases, may have longer-term effects on fertility. While fertility does dip during treatment, many young women have successfully undergone therapy and later had children. Today, doctors are increasingly offering fertility preservation options, such as freezing eggs or embryos before treatment begins, to give women more choices for the future.
Breast surgery typically comes into the picture as one of the first major steps in breast cancer treatment. In cases where the cancer is caught early and remains localized, surgery is often performed immediately to remove it. If the tumor is small, a lumpectomy (removal of just the lump and some surrounding tissue) may be enough. For larger tumors or when cancer involves multiple areas of the breast, a mastectomy (removal of the whole breast) may be recommended. In other situations, doctors may begin with chemotherapy to shrink the tumor, making surgery easier and less invasive. Surgery can also include removing lymph nodes under the arm to check if the cancer has spread. The timing and type of surgery depend on the stage of the cancer, overall health, and the woman’s preferences, but it remains one of the critical aspects of breast cancer care.
The decision between a lumpectomy and a mastectomy has also been a challenge for many women and depends on factors like the size and location of the tumor, whether multiple tumors are present, and sometimes, the patient’s own preference. Both approaches can be highly effective, and in many cases, they are paired with additional treatments such as radiation therapy, chemotherapy, or hormone therapy to reduce the chance of recurrence.
One of the most encouraging advances in modern medicine is the shift toward personalized medicine. In the past, breast cancer was treated as a single disease. Today, doctors analyze tumors at a genetic and molecular level to determine the best approach for each patient. For example, some cancers are fueled by hormones and respond well to drugs that block estrogen production, while others carry changes in specific genes and can be treated with targeted therapies. This precision-based care has significantly improved outcomes, offering women not just longer survival but better quality of life.
Genetics plays an important role in understanding breast cancer risks. Many people have heard of BRCA1 and BRCA2, but the terms can sound intimidating and abstract. These are simply genes we all have. In their normal form, they act like repair workers, fixing broken DNA and helping prevent cancer from developing. But when there is an inherited fault, or mutation, in one of these genes, the repair system doesn’t work properly. As a result, the risk of breast and ovarian cancer rises sharply. Women with these impaired genes can face up to a 70% lifetime risk of breast cancer compared to the much lower risk in the general population. The good news is that genetic testing can help identify women who carry these mutations, allowing for closer monitoring and preventive options.
Life after treatment is another area where medicine has made significant advancements. For women who undergo mastectomy, breast reconstruction can help restore the breast’s shape using either saline/ silicone implants or tissue from another part of the body. Reconstruction not only helps with physical recovery but also plays a powerful role in emotional and psychological healing. The focus in modern breast cancer care is not only on survival but also on ensuring women live full, dignified lives after their treatment.
Several risk factors are known to increase the likelihood of breast cancer. These include obesity, smoking, heavy alcohol use, long-term hormone replacement therapy after menopause, and even certain herbal treatments that contain estrogen-like compounds. However, having a risk factor does not mean a woman will definitely get cancer; it simply highlights the need for vigilance and regular checkups.
In Kenya and across much of sub-Saharan Africa, one of the greatest challenges remains late diagnosis. Many women present to hospitals at advanced stages of the disease, when treatment options are more limited and survival rates are lower. The barriers include the high cost of diagnosis and treatment, fear of the disease, and limited access to specialists and diagnostic tools, especially in remote areas.
Breast cancer is not a death sentence. But it can become deadly if the diagnosis is delayed. Early detection, timely treatment, and consistent follow-up are the keys to survival. Go for your screening today and get to know your breasts. Breast cancer, when caught early, is often treatable, and with the advances in care today, survival and recovery are more possible than ever before.
By Dr. Mukuhi Ng’ang’a, Consultant Breast Surgical Oncologist at Aga Khan University Hospital, Nairobi
About Soko Directory Team
Soko Directory is a Financial and Markets digital portal that tracks brands, listed firms on the NSE, SMEs and trend setters in the markets eco-system.Find us on Facebook: facebook.com/SokoDirectory and on Twitter: twitter.com/SokoDirectory
- January 2026 (220)
- February 2026 (243)
- March 2026 (72)
- January 2025 (119)
- February 2025 (191)
- March 2025 (212)
- April 2025 (193)
- May 2025 (161)
- June 2025 (157)
- July 2025 (227)
- August 2025 (211)
- September 2025 (270)
- October 2025 (297)
- November 2025 (230)
- December 2025 (219)
- January 2024 (238)
- February 2024 (227)
- March 2024 (190)
- April 2024 (133)
- May 2024 (157)
- June 2024 (145)
- July 2024 (136)
- August 2024 (154)
- September 2024 (212)
- October 2024 (255)
- November 2024 (196)
- December 2024 (143)
- January 2023 (182)
- February 2023 (203)
- March 2023 (322)
- April 2023 (297)
- May 2023 (267)
- June 2023 (214)
- July 2023 (212)
- August 2023 (257)
- September 2023 (237)
- October 2023 (264)
- November 2023 (286)
- December 2023 (177)
- January 2022 (293)
- February 2022 (329)
- March 2022 (358)
- April 2022 (292)
- May 2022 (271)
- June 2022 (232)
- July 2022 (278)
- August 2022 (253)
- September 2022 (246)
- October 2022 (196)
- November 2022 (232)
- December 2022 (167)
- January 2021 (182)
- February 2021 (227)
- March 2021 (325)
- April 2021 (259)
- May 2021 (285)
- June 2021 (272)
- July 2021 (277)
- August 2021 (232)
- September 2021 (271)
- October 2021 (304)
- November 2021 (364)
- December 2021 (249)
- January 2020 (272)
- February 2020 (310)
- March 2020 (390)
- April 2020 (321)
- May 2020 (335)
- June 2020 (327)
- July 2020 (333)
- August 2020 (276)
- September 2020 (214)
- October 2020 (233)
- November 2020 (242)
- December 2020 (187)
- January 2019 (251)
- February 2019 (215)
- March 2019 (283)
- April 2019 (254)
- May 2019 (269)
- June 2019 (249)
- July 2019 (335)
- August 2019 (293)
- September 2019 (306)
- October 2019 (313)
- November 2019 (362)
- December 2019 (318)
- January 2018 (291)
- February 2018 (213)
- March 2018 (275)
- April 2018 (223)
- May 2018 (235)
- June 2018 (176)
- July 2018 (256)
- August 2018 (247)
- September 2018 (255)
- October 2018 (282)
- November 2018 (282)
- December 2018 (184)
- January 2017 (183)
- February 2017 (194)
- March 2017 (207)
- April 2017 (104)
- May 2017 (169)
- June 2017 (205)
- July 2017 (189)
- August 2017 (195)
- September 2017 (186)
- October 2017 (235)
- November 2017 (253)
- December 2017 (266)
- January 2016 (164)
- February 2016 (165)
- March 2016 (189)
- April 2016 (143)
- May 2016 (245)
- June 2016 (182)
- July 2016 (271)
- August 2016 (247)
- September 2016 (233)
- October 2016 (191)
- November 2016 (243)
- December 2016 (153)
- January 2015 (1)
- February 2015 (4)
- March 2015 (164)
- April 2015 (107)
- May 2015 (116)
- June 2015 (119)
- July 2015 (145)
- August 2015 (157)
- September 2015 (186)
- October 2015 (169)
- November 2015 (173)
- December 2015 (205)
- March 2014 (2)
- March 2013 (10)
- June 2013 (1)
- March 2012 (7)
- April 2012 (15)
- May 2012 (1)
- July 2012 (1)
- August 2012 (4)
- October 2012 (2)
- November 2012 (2)
- December 2012 (1)
